论文部分内容阅读
目的探讨常规凝血检验项目在异位妊娠大出血输血治疗疗效的监测和预测中的作用。方法选取我院收治的异位妊娠大出血行成分输血治疗的患者305例进行研究,依据患者是否发生不良反应划分为对照组284例(无不良反应)和观察组21例(不良反应组)。对两组患者的血常规检测结果和凝血功能指标方面存在的差异进行研究。结果两组在输血后血常规指标均显著改善,对照组改善程度优于观察组(P<0.05);两组输血后,观察组凝血功能指标上升,对照组除FIB上升外,其余指标均有所下降,两组对比差异显著(P<0.05)。结论对于异位妊娠大出血输血治疗的患者进行常规凝血项目指标检验,对于临床治疗效果及不良反应的监测与预测有一定的意义,可以作为临床指导的一项依据。
Objective To investigate the role of routine coagulation test in the monitoring and prediction of therapeutic efficacy of ectopic pregnancy bleeding. Methods A total of 305 patients with ectopic pregnancy hemorrhage undergoing transfusion therapy were enrolled in this study. According to the patients’ adverse reactions, they were divided into control group (284 cases without adverse reactions) and observation group (21 cases) (adverse reactions group). The differences between the two groups in blood routine test and coagulation test were studied. Results After the blood transfusion, the blood routine indexes of both groups were significantly improved, and the improvement degree of the control group was better than that of the observation group (P <0.05). After the blood transfusion of two groups, the coagulation function indexes of the observation group increased, while those of the control group except FIB increased The difference between the two groups was significant (P <0.05). Conclusions The routine blood coagulation test in patients with ectopic pregnancy hemorrhage transfusion test has some significance for clinical treatment and adverse reactions monitoring and prediction, which can be used as a basis for clinical guidance.